Clinical Trials Logo
  1. Home
  2. Renal Function Disorder
  3. NCT01255020

Renal Protective Effects of Restricted Protein Dietary With α-keto Acid in CAPD Patients

Renal Function Disorder Clinical Trial

Official title:
Safety and Efficacy Evaluation of Restricted Protein Dietary Supplemented With α-keto Acid on Protecting Residual Renal Function in CAPD Patients——A Prospective, Double Blind Randomized, Parallel Control, Multi-center Clinical Trial

Clinical Trial Summary

The prospective, double blind randomized, parallel control, and multi-center clinical trial will evaluate the safety and efficacy of α-keto acid with restricted protein diet on protecting residual renal function in continuous ambulatory peritoneal dialysis (CAPD) patients.

Clinical Trial Description

Residual renal function (RRF) is associated with cardiovascular complication, nutritional status, incidence of peritonitis, and quality of life in peritoneal dialysis (PD) patients. Therefore, RRF is an important determinant of mortality and morbidity in PD patients.

Previous studies have suggested that dietary protein restriction supplemented with α-keto acids may slow the loss of RRF in chronic kidney disease patients. However, these trials are small sample and short-time research. In PD patients, there is very few reports to indicate the effect of α-keto acid with restricted protein diet on RRF.

The aim of this study is to evaluate the safety and efficacy of α-keto acid with restricted protein diet on protecting residual renal function in continuous ambulatory peritoneal dialysis (CAPD) patients.This is a prospective, double blind randomized, parallel control, and multi-center clinical study. 160 patients who meet Inclusion/Exclusion criteria will be randomized into α-Keto Acid group or control group at the ratio of 1:1. The α-Keto Acid group will use compound α-Keto Acid plus restricted protein diet, while control group will use placebo plus restricted protein diet.The α-Keto Acid dosage is 100mg/kg/d daily. The restricted protein dosage is 1g/kg/d. The safety and efficacy of α-Keto Acid with restricted protein diet on RRF will be evaluated after 1 year treatment. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01255020
Study type Interventional
Source Sun Yat-sen University
Contact
Status Completed
Phase N/A
Start date March 2010
Completion date December 2013
View Details
See also
  Status Clinical Trial Phase
Completed NCT02522104 - Evaluation of the Impact of Renal Function on the Pharmacokinetics of SIKLOS ® (DARH) Phase 4
Completed NCT00721773 - Renal Protective Effects of Renin Angiotensin System (RAS) Inhibitor in Peritoneal Dialysis Patients N/A
Enrolling by invitation NCT02256579 - Utility of Urinary beta2 Microglobulin as an Early Marker of Renal Dysfunction in Vietnamese HIV-Infected Patients N/A
Completed NCT04069871 - Transcutaneous Electrical Nerve Stimulation for Tissues Perfusion N/A
Active, not recruiting NCT05087537 - Effect of Concomitant Bladder Neck Incision and Urethral Valve Ablation on Surgical Re-intervention Rate for Patients With Posterior Urethral Valve N/A
Active, not recruiting NCT05054972 - Left Renal Vein Division for Juxtarenal Aortic Exposure
Not yet recruiting NCT05112393 - Development and Validation of Creatinine-Based Estimates of the Glomerular Filtration Rate Equation
Recruiting NCT05462938 - Conscious Sedation for Transcatheter Aortic Valve Implantation N/A
Recruiting NCT04272359 - Substitution of Sulfonylureas With New Generation of Hypoglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus
Active, not recruiting NCT03002415 - The Effect of Water Intake on the State of Hydration and Renal Function in Elderly Patients N/A
Active, not recruiting NCT04242758 - Phthalates Exposure in Type 2 Diabetic Patients and Diuretic Therapy Phase 4
Withdrawn NCT00936923 - Effect of Diuretics on Fluid Status Control and Residual Renal Function in Peritoneal Dialysis Patients Phase 3
Recruiting NCT04028323 - Functional MRI-based Assessment of Terlipressin vs. Octreotide on Renal Function in Cirrhotic Patients With Acute Variceal Bleeding (CHESS1903) Phase 4
Completed NCT04070885 - Cohort Follow-up: Progression and Consequences of Chronic Kidney Disease.
Completed NCT02549066 - Impact of CArdiopulmonary Bypass Flow on Renal Blood Flow, Function and OXygenation N/A
Not yet recruiting NCT02061566 - Indoxyl Sulfate Induces Leukocyte-endothelial Interactions Through Up-regulation of ICAM-1 in Acute Kidney Injury N/A
Not yet recruiting NCT05134077 - Influence of Simple Renal Cysts on Renal Function N/A
Completed NCT02013596 - Transcutaneous Electrical Acupoint Stimulation(TEAS) for Hepatic and Renal Dysfunction After Pneumoperitoneum N/A
Completed NCT02443363 - Estimated Glomerular Filtration Rate After Kidney Transplantation - the Formula MDRD, CKD-EPI or Cockroft-Gault? N/A
Completed NCT01948336 - The Effects of Dexmedetomidine on Early Stage Renal Functions in Pediatric Patients Phase 4